Cytori Therapeutics buy marge
Start price
13.04.17
/
50%
?0.97
Target price
03.01.18
€1.80
Performance (%)
-73.76%
End price
03.01.18
€0.25
Summary
This prediction ended on 03.01.18 with a price of €0.25. The BUY prediction by marge for Cytori Therapeutics performed very badly with a performance of -73.76%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytori Therapeutics | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by marge for this prediction
In the thread Cytori Therapeutics diskutieren
marge stimmt der Buy-Einschätzung von zeckenjoe zu
Cytori Therapeutics (CYTX) announces that the FDA has approved an Investigational Device Exemption
(IDE) for a pilot clinical trial to evaluate Cytori Cell Therapy in patients with thermal burn injury,
with shares ahead 23% premarket, and announced 10.04 that it intends to offer and sell shares of its common stock in an underwritten public offering, with shares down -36%.
Trading hoch 3
(Vom Mitglied beendet)